Supporters for recreational marijuana hope the November election will bring their first major electoral victory. Supporters believe “yes” votes in the Northeast region of the United States would add geographic variety to the legalization map, inspiring other East Coast states to move in similar directions and perhaps build toward ending federal exclusions on marijuana.
ChineseInvestors.com Inc. (OTCQB: CIIX) has entered a strategic investment into a recent public listing of a company dedicated to consulting services that covers all aspects of cannabis cultivations, Medicine Man Technologies, Inc. (OTCQB: MDCL). Medicine Man Technologies Inc.’s currently has a pending acquisition of Pono Publications Inc. and Success Nutrients Inc. which could boost its current position as a leading provider of cultivation technologies. Companies are moving ahead now to bring the benefits of combined experience and technologies to a market occupied by marijuana growers in need of augmented efficiency.
Chineseinvestors.com, Inc. announces today that it will launch the world’s first Chinese-language subscriber-only information service specifically focused on emerging growth companies in the Cannabis sector. The new service’s mission is to locate and identify select equities with the greatest potential for capital appreciation. The content of this service will cover the medical and recreational cannabis markets, the latest trends and technologies in the industry, and any investment opportunities in either private or publicly traded cannabis companies. The subscription service is expected to be launched after January 1st, 2017.
Mr. Wang further remarked: “Compared to our peers, ChineseInvestors.com has a clear lead in early research of the cannabis industry. Our investment in MDCL has already increased more than 400% in value this year. We believe that our broad networking circle and professional research methods will provide our Chinese-speaking subscribers with unique opportunities to research cannabis companies. Although some investors among Chinese communities still have bias against cultivation and sales of cannabis, we must also acknowledge the existence of huge potential business opportunities within this sector, and we are starting to see valuations in the cannabis industry gradually becoming more reasonable after reaching their peak in 2014.”